Core Insights - The 8th China International Import Expo (CIIE) took place from November 5 to 10 in Shanghai, showcasing GE Healthcare's commitment to innovation in the medical field with nearly 40 new products and solutions, including 18 product launches and 9 global debuts, with 60% developed by Chinese teams [1][3] Group 1: Innovation and Product Launches - GE Healthcare's participation at CIIE highlighted a record number of new products, with a significant focus on precision diagnosis, interventional and surgical treatment, and the integration of digital and physical solutions [1][3] - The company has introduced over 50 new products into clinical application over the past eight years, emphasizing its deepening local presence in China [3] Group 2: Collaborations and Ecosystem Development - GE Healthcare has established multiple collaborations with industry associations, partners across the supply chain, and research institutions to promote the clinical application of medical innovations [3] - The company is working with Beijing Children's Hospital on a low-dose CT scanning protocol, which aims to benefit 20 hospitals in Yunnan, demonstrating a commitment to enhancing specialized diagnostic capabilities [3] Group 3: Strategic Vision and Future Plans - GE Healthcare aims to integrate its corporate strategy with China's development framework during the upcoming 14th Five-Year Plan, focusing on building a precision medical ecosystem [4] - The company has initiated a five-year investment plan of 500 million yuan to enhance its MRI research and development capabilities at its Tianjin base, which will handle over half of GE Healthcare's global MRI product development tasks [3]